@article{0f73210b609c46b98ac71be0e0bf50b1,
title = "Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance",
keywords = "COVID-19",
author = "Qi Su and Lau, {Raphaela Iris} and Qin Liu and Chan, {Francis Ka Leung} and Ng, {Siew Chien}",
note = "Funding Information: FKLC and SCN are the scientific co-founders and sit on the board of Directors of GenieBiome Ltd. SCN has served as an advisory board member for Pfizer, Ferring, Janssen, and Abbvie and a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie, and Takeda. She has received research grants from Olympus, Ferring, and Abbvie. FKLC has served as an advisor and lecture speaker for Eisai Co. Ltd., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Co., and Takeda (China) Holdings Co. Ltd. All other co-authors declare no competing interests. Funding Information: This work was supported by The Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region. The authors are partially supported by InnoHK, The Government of Hong Kong, Special Administrative Region of the People{\textquoteright}s Republic of China. R.I.L. received additional support from the Hong Kong PhD Fellowship Scheme (HKPFS).",
year = "2023",
month = jun,
day = "1",
doi = "10.1136/gutjnl-2022-328319",
language = "English",
volume = "72",
pages = "1230--1232",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "6",
}
